HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama

Clinical trial NCT04627363 · UNKNOWN

Trial details

NCT number: NCT04627363
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Bevacizumab Liver Neoplasms Toripalimab Oxaliplatin

Start date: 2021-01-01
Primary completion: 2022-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.